Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Monday.com | MNDY | Jan 10, 2025 | 218.47 | -3.92 |
Mondelez International A | MDLZ | Jan 10, 2025 | 56.25 | -3.50 |
Moneyhero | MNY | Jan 10, 2025 | 1.13 | -0.88 |
MoneyLion A | ML | Jan 10, 2025 | 85.75 | -0.80 |
MongoDB A | MDB | Jan 10, 2025 | 245.22 | -1.39 |
Monogram Technologies | MGRM | Jan 10, 2025 | 2.50 | 0.00 |
Monolithic Power Systems | MPWR | Jan 10, 2025 | 591.23 | -4.79 |
Monopar Therapeutics | MNPR | Jan 10, 2025 | 25.35 | +3.64 |
Monro | MNRO | Jan 10, 2025 | 21.97 | -1.13 |
Monroe Capital | MRCC | Jan 10, 2025 | 8.15 | -3.55 |
Monster Beverage | MNST | Jan 10, 2025 | 49.74 | -3.60 |
Montauk Renewables | MNTK | Jan 10, 2025 | 4.12 | -5.07 |
Monte Rosa Therapeutics | GLUE | Jan 10, 2025 | 5.70 | -4.84 |
Montrose Environmental Group | MEG | Jan 10, 2025 | 21.56 | +3.65 |
Moodys | MCO | Jan 10, 2025 | 452.81 | -4.09 |
Moog A | MOG-A | Jan 10, 2025 | 199.63 | -1.55 |
Moog B | MOG-B | Jan 10, 2025 | 199.39 | 0.00 |
Moolec Science | MLEC | Jan 10, 2025 | 0.89 | -0.01 |
MoonLake Immunotherapeutics | MLTX | Jan 10, 2025 | 46.31 | -3.85 |
Morgan Stanley | MS | Jan 10, 2025 | 123.45 | -3.45 |
Morgan Stanley China A Share Fund | CAF | Jan 10, 2025 | 12.05 | -1.79 |
Morgan Stanley Direct Lending Fund | MSDL | Jan 10, 2025 | 20.52 | -0.05 |
Morgan Stanley Emerging Markets Debt Fund | MSD | Jan 10, 2025 | 7.67 | -1.29 |
Morgan Stanley Emerging Markets Domestic Debt Fund | EDD | Jan 10, 2025 | 4.43 | -0.89 |
Morgan Stanley FXDFR Pref | MS-K | Jan 10, 2025 | 24.06 | -0.87 |
Morgan Stanley India Investment Fund | IIF | Jan 10, 2025 | 24.95 | -1.56 |
Morgan Stanley Pref A | MS-A | Jan 10, 2025 | 23.63 | -0.13 |
Morgan Stanley Pref E | MS-E | Jan 10, 2025 | 25.33 | -0.04 |
Morgan Stanley Pref F | MS-F | Jan 10, 2025 | 25.25 | +0.42 |
Morgan Stanley Pref I | MS-I | Jan 10, 2025 | 25.01 | -0.28 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.